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Abstract
Staphylococcus pseudintermedius affecting dogs is analogous to S. aureus on humans,
acting as both normal flora and opportunistic pathogen. Methicillin resistance in S.
pseudintermedius is recent, with the first documented occurrence of an isolate bearing
the methicillin resistance gene, mecA, in 1999. This gene encodes penicillin binding
protein 2a, which renders all beta-lactam drugs ineffective and functions as a “gateway”
antibiotic resistance determinant. In the presence of ineffective antibiotics,
opportunities for mutational events and acquisition of mobile genetic elements increase
as microbial densities increase, often leading to multi-drug resistance. Methicillinresistant S. pseudintermedius (MRSP) infections have become increasingly common. For
example, approximately 30% of the S. pseudintermedius isolates tested by the
University of Tennessee College of Veterinary Medicine Diagnostic Bacteriology service
are resistant to methicillin. An increasing number of MRSP isolates are also resistant to
most clinically useful antibiotics available to veterinarians except for chloramphenicol,
and resistance to this antibiotic is common among European MRSP isolates.
Chloramphenicol resistance has begun to appear in the US and if this trend continues
there may soon be few viable antibiotic treatment options.
Compared with the arrival of methicillin-resistant S. aureus in the 1960s, the
opportunity currently exists to apply advanced molecular methods early in this
recognized emergence of MRSP. To that end I have pursued projects utilizing multilocus
sequence typing, pulsed-field electrophoresis, and SCCmec characterization of both
susceptible and resistant S. pseudintermedius. The initial result was the detection of a
clonal population of MRSP in the southeastern United States. Further characterization
of this and other clonal lineages using genomic sequencing and real-time RT-PCR
expression analysis of antibiotic resistance and quorum sensing genes revealed a
marked difference in the regulation of antibiotic resistance between regional clones.
These discoveries have interesting epidemiological implications and provide a
foundation for the development of novel therapeutics to circumvent the expanding
antibiotic resistance repertoire of MRSP. Potential targets identified by this work
include membrane-bound beta-lactamase receptors responsible for the regulation of
mecA, non-cognate auto-inducing peptides, and synthetic antisense oligonucleotides.
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Chapter 1: Literature Review
Overview

A synthetic form of penicillin, methicillin, was introduced in 1959 to treat
Staphylococcus aureus resistant to beta-lactam antibiotics. Within a year the first
methicillin-resistant S. aureus (MRSA) isolates began to appear in hospital settings.2
Methicillin-resistance is a “gateway” antibiotic resistance determinant. It causes
penicillins and cephalosporins to become ineffective, establishing a MRSA foothold in
the hospital environment and on the patient and hospital staff repeatedly exposed to
first-line antibiotics. From that foothold, the organism has the opportunity to acquire
mutations and further transmissible elements that increase its multi-drug resistance
repertoire. Methicillin-resistance often leads to multi-drug resistance. In the fifty years
since methicillin resistance appeared in S. aureus, MRSA infection has become the sixthleading cause of death in hospitalized human patients in the United States, with costs
estimated to be between 4 and 6 billion dollars annually.2,3
Staphylococcus pseudintermedius on dogs is analogous to S. aureus on humans, acting
as both normal flora and opportunistic pathogen. It is the primary cause of pyoderma,
the most common dermatologic disease seen in dogs, and is also frequently associated
with urinary tract infections and wound and surgical site infections.4 The first
documented isolate of S. pseudintermedius bearing the methicillin resistance gene mecA
occurred in 1999.5 Since that discovery, methicillin-resistant S. pseudintermedius (MRSP)
infections have become increasingly common. Approximately 30% of the staphylococcal
isolates tested by the University of Tennessee College of Veterinary Medicine (UTCVM)
Bacteriology Service are resistant to methicillin.6-8 These bacteria also carry resistance to
almost all clinically useful antibiotics except for chloramphenicol and the ones reserved
for use in humans. Resistance to chloramphenicol is now beginning to appear, leaving
no viable therapeutic options.
Methicillin resistance in S. aureus has been studied in far greater detail than in S.
pseudintermedius; despite significant dissimilarities in genomic sequence the two
species share a natural history, as well as many of the same regulatory, antimicrobial,
and virulence determinants. Biochemical and molecular techniques used in the study of
S. aureus can and have often been adapted to S. pseudintermedius. Therefore, much of
the literature regarding S. aureus is applicable to the study of staphylococci as a whole.
1

The following is a review of the nomenclature, phenotype, genetic characterization of
methicillin resistance, and typing methodologies for S. pseudintermedius.

The Taxonomic History of Staphylococcus pseudintermedius

The defining characteristics of bacterial species have changed with advances in
technology. With the proliferation of molecular characterization techniques and the
increased accessibility of genomic sequencing platforms, the inevitable taxonomic trend
is toward diversification within the bacterial genus. The 19 th century Scottish physician
Alex Ogston was an early proponent of the role of microscopic spherical organisms
(“micrococci”) in acute inflammation and suppuration associated with abscess
formation in skin. He was also one of the first to make the leap connecting microbial
abscessation with the circulatory phenomena of septicemia and pyemia.9,10 These
foundational observations hold true in the clinical presentation of staphylococcal
infection today. In 1882 he coined the term Staphylococcus – from the Greek staphulê
for bunch of grapes – to differentiate cluster-forming micrococcus from the chainforming variety then known as Billroth’s streptococci.11 Rosenbach further subdivided
staphylococci in 1884 on the basis of color on culture media – S. aureus and S. albus for
gold and white colony formation respectively.12 For the next ninety years
Staphylococcus was widely held to have only three distinct species. During this period
gram-positive, coagulase-positive, hemolytic isolates with variable colony coloration and
associated with disease in both humans and animals were presumed to be S. aureus;
whereas non-pathogenic, coagulase-negative staphylococci (CoNS) with white colony
coloration were classified as either S. epidermidis (formerly albus) or S. saprophyticus
and considered to be environmental contaminates.12-14
Review of veterinary microbiology textbooks from the 1930s through the late 1960s
supports the bias towards S. aureus as the catchall designation for pathogenic grampositive and coagulase-positive clustering cocci. Variations in S. aureus microscopic size,
hemolytic ability, and colony coloration were often noted, prompting calls for greater
research into the validity of species designation.15-18 From Merchants 1968 edition of
Veterinary Bacteriology and Virology the follow observation is made concerning the use
of pigmentation as the sole criteria for staphylococcal differentiation,
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(S. epidermidis) has been considered by many to be only a nonpigmented variant of the aureus strains. It is readily apparent to those
who study the staphylococci that numerous non-pigmented strains can
be isolated. In fact, unless isolation is made upon special media, such as
no. 110, colonies of staphylococci are sometimes white.
The designation of strains of any organism, one variety or
another, on the basis of colony color without specification of growth is
most confusing, not only to the student but to anyone interested in
taxonomy. . . .
It is quite apparent that additional research must be done on the
genus Micrococcus (Staphylococcus) in order to clarify many of the
interrelationships of the members of this genus.15

This admonition in a standard veterinary text of the time suggests that as late as the
early 1970s some veterinary practitioners were dismissing the as yet uncharacterized S.
intermedius as nonpathogenic based primarily on colony color.
In the latter half of the 20th century, spurred by the emergence of new hospital-acquired
and antibiotic-resistant infections, both human and veterinary medical microbiologists
began to actively pursue a better understanding of which organisms were associated
with specific types of infections and hosts. The improvements made in both phenotypic
biochemical testing and genotypic molecular tests resulted in the diversification of both
coagulase-positive and negative staphylococcal species.13,16,19 At the time of writing
there are 41 species and 24 subspecies cited in the genus Staphylococcus.20
The earliest call for a more precise designation for coagulase-positive staphylococci of
canines came in 1947, with Smith’s observation that not all suspected pathogenic strains
from canines reacted uniformly in tube, slide and plate agglutination tests; and that
canine isolates were discernable from those of other animals by cultural characters and
toxin formation.21 Based upon confirmation of Smith’s work, a 1967 report proposed the
name S. aureus var. canis and described biochemical and staining differences between
isolates from different host species. The study showed that canine isolates consistently
failed to coagulate human serum, pigmentation lacked the characteristic golden hue,
and crystal-violet staining, fibrinolysin production, hemolysis type and phage type did
not consistently match between human and canine isolates.22 A series of cross-reactivity
3

experiments by I. Live of Pennsylvania and V. Hajek of Czechoslovakia further explored
the coagulase and fibrinolysis disconnect observed when isolates of one background
were exposed to blood components of the other. Not only did these findings have
bearing on speciation, they were an early suggestion that staphylococci of canine origin
may be more host-adapted than the human equivalent, S. aureus.23-25 In 1976 Hajek
reported the results of a battery of additional biochemical tests that when applied to
coagulase-positive staphylococci of animal origin (pigeon, canine, mink, and horse)
justified a new species name, S. intermedius. The name was chosen to indicate the
group’s intermediate phenotypic position between the coagulase-positive S. aureus and
the white colony formation of S. epidermidis. Despite evidence of biochemical
differences between isolates from the different animals within the study, a pigeon
isolate became the type strain for S. intermedius.16 With the biochemical profile
established for species identification, reports from the 1980s through 2007 consistently
demonstrated S. intermedius to be the primary staphylococcal normal flora and
opportunistic pathogen of canines.26-30
The improvement of molecular typing methods in the 1980s and 90s provided additional
tools for the description of bacterial species. In 2005 Devriese et al. described a novel
staphylococci based on 16S rRNA gene sequence analysis and confirmed by DNA-DNA
hybridization its dissimilarity with S. intermedius, S. delphini and S. schleiferi subsp.
schleiferi type strains. The name S. pseudintermedius was chosen because the new
species was difficult to distinguish from S. intermedius with standard phenotypic tests.31
Because 16S rRNA gene sequence differed so little (>99% homology) among the S.
intermedius group (SIG includes S. intermedius, S. delphini, and S. pseudintermedius),
subsequent research expanded phylogenetic analysis with sodA and hsp60 gene
sequences. Whereas the Devriese group based its findings on four isolates, one each
from a cat, dog, horse and parrot, Sasaki et al. analyzed 117 isolates with the S.
intermedius phenotype and primarily of canine and pigeon origin. They found that all
canine isolates (n=78) were S. pseudintermedius and that all pigeon isolates were not.
The ATCC S. intermedius type strain (acquired from the Hajek 1976 study) clustered only
with isolates from wild pigeons. This finding was the first strong indication that the
newly identified S. pseudintermedius was inherently linked to the canine host.32
Further evidence for replacing S. intermedius with S. pseudintermedius as the
opportunistic staphylococcal pathogen of canines was given by Bannoehr et al. in 2007.
The group created a four-component multilocus sequence typing (MLST) analysis using
chaperonin 60 (cpn60), phosphate acetyltransferase (pta), elongation factor tu (tuf), and
accessory gene regulator locus D (agrD) in addition to 16S rRNA. They tested 105 SIG
4

isolates from various hosts and from ten countries in North America, Europe, and Asia.
Their findings mirrored those of Sasaki et al. in that all S. pseudintermedius isolates
identified with this method were found on dogs.33 Based upon these studies the current
consensus for SIG nomenclature is to categorize as S. pseudintermedius all canine
isolates that have the S. intermedius phenotype. Therefore, the following terms and
abbreviations are a convenient method of classification31,34,35:
1. S. (pseud)intermedius when isolates previously identified as S.
intermedius are likely S. pseudintermedius (obtained from a canine host)
2. MRS(P)I for methicillin-resistant S. (pseud)intermedius (formerly
classified as MRSI but obtained from a canine host)
3. MRSP for isolates identified as S. pseudintermedius via methods that
have appeared in more recent literature. 34,35

The History of Methicillin Resistance in S. pseudintermedius

In studies from the 1980s, all veterinary staphylococcal isolates tested were susceptible
to methicillin.36,37 The first report of methicillin resistance in S. (pseud)intermedius
confirmed by PCR detection of mecA occurred in 1999 from a single isolate in a survey of
25 staphylococcal isolates of canine origin. In that study, both coagulase-positive and
negative isolates were screened; but interestingly, all other coagulase-positive
methicillin-resistant isolates were found to be S. aureus. This occurred at the University
of Illinois, and the sample set had been collected from 1995 forward. Several possible
explanations exist for the detection and/or emergence of a single and novel MRS(P)I at
this time. The first is that a confluence of events provided the necessary elements for
acquisition of the mecA gene by S. (pseud)intermedius:
1. A high prevalence of MRSA among staphylococci responsible for hospitalacquired infections (>50%) meant that the raw numbers of mobile
genetic elements (MGE) bearing mecA were high relative to the past.35
2. The emergence of CA-MRSA infections not linked to HA-MRSA indicated
that MGEs had made the intra-species transition from one set of lineages
to another – mecA and SCCmec was on the move.38
3. The use of beta-lactam antibiotics and cephalosporins in human and
animal medicine, as well as in food animal production may have reached
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a critical mass, facilitating not only the acquisition, but also the
maintenance of the SCCmec bearing mecA in S. (pseud)intermedius.39,40
While all these elements were certainly in place, another reason for the later arrival of
methicillin resistance in the S. intermedius literature relative to its arrival in S. aureus
may simply be due to the sensitivity of speciation and screening methodologies. The
Spanish group Piriz et al. reported an apparently novel and large proportion of
methicillin-resistant isolates in a sampling of S. (pseud)intermedius collected between
1988 and 1992; however, they did not verify the presence of mecA and found widely
varying levels of methicillin resistance when adjusting the culture alkalinity for canine
physiology.41 It is important to consider that the speciation of coagulase-positive
staphylococci was nebulous prior to the mid-1970s, and that appropriate standards for
speciation and methicillin resistance determination in staphylococci of animal origin
continue to evolve through the present.6 When molecularly screening UTCVM isolates
and samples submitted by collaborators for species identity, the Bacteriology and
Immunology Services often find S. aureus, S. pseudintermedius, S. intermedius, S.
delphini and S. schleiferi coagulans phenotypically misidentified. Perhaps S. intermedius
lineages bearing the mecA gene existed for some time prior to the mid-1990s and were
misclassified as MRSA or expressed mecA at less detectable levels when tested using S.
aureus standards. The exact point in time where S. pseudintermedius acquired mecA is
not vital to present treatment and control of MRSP expansion. However, historical
review of the literature provides a foundation and informs upon how mecA might move
from one organism to another, and from what ecological repositories resistance genes
like mecA arise. Understanding the frequency and mode of SCCmec horizontal transfer,
through in-depth molecular population analysis, enables the identification of clinically
relevant MRSP lineages and sheds light on the frequency at which novel lineages
appear.

The Utility of Genotypic Methods for Staphylococcal Population Analysis
Horizontal gene transfer (HGT) incidence is an important part of determining zoonotic
potential of MRSP. As yet there is no evidence that SCCmec from canine normal flora S.
pseudintermedius can transfer to human S. aureus or vice versa. Interspecies SCCmec
transfer is likely a rare event in that no research group has yet demonstrated such
movement experimentally. However, there is compelling evidence from a 2001 Dutch
6

case report concerning a premature infant treated with potentiated amoxicillin while in
a neonatal intensive care unit. Prior to antibiotic therapy a mecA negative MSSA was
cultured. Following antibiotic treatment failure ten days later, a MRSA was isolated with
the same genetic background as the previously identified MSSA, as well as CoNS with an
identical SCCmec to that of the MRSA.42 The neonatal intensive care unit had strict
infection control procedures in place, and cultured at all stages of treatment. One
plausible explanation for the appearance of this novel MRSA was that the SCCmec
transferred from CoNS to MSSA and the antibiotic given insured selection of the newly
formed MRSA.
Investigations of MRSA genotype in large populations are essentially attempting to
replicate the findings on the Dutch baby at the regional or national level. Understanding
the movement of SCCmec requires that researchers adopt a consistent typing scheme.
Prior to the molecular age, tools for bacterial characterization included phenotypic
speciation, antibiogram profile, and phage typing. Over the past two decades
methodologies have been developed that allow investigators to apply numerical values
to genetic relatedness within a species. Molecular techniques have also been
developed that describe the relatedness of resistance cassettes SCCmec. The following is
a summary of genotypic methods applied to staphylococci. These are some of the
approaches that can demonstrate associations between bacterial lineages and
resistance determinanants.

Staphylococcal Cassette Chromosome (SCCmec) Typing

Known SCCmecs are relatively large for MGEs, ranging in size from 30 to 55KB. The
essential components used to characterize SCCmec are the genetic sequences of the
mec and ccr gene complexes. The mec operon is composed of mecA, a promoter region,
and some or all of the regulatory genes mecI (promoter inhibitor) and mecR1
(membrane-bound -lactam sensor). The ccr gene complex encodes the recombinases
responsible for cassette excision from and integration into the bacterial chromosome. 43
To date sequence analysis has identified five classes of mec complex (A, B, C1, C2, and E
based upon the completeness of the operon) and five ccr allotypes (ccrAB1 to ccrAB4
and ccrC) in major MRSA lineages. SCCmec type is designated by a roman numeral (IVIII) and represents a combination of mec class and ccr allotype.44 Because the cassettes
are so large, extensive sequencing would be required to fully characterize each one. To
7

bypass this laborious process, numerous multiplex PCR schemes have been described,
amplifying sequences specific to each mec and ccr region by SCCmec type. The inherent
drawback to these PCR-based techniques is that any novel cassette type is either
misclassified because the small regions amplified by the assay are by chance similar to
the described cassette type, or it is untypeable and must be fully sequenced and a new
multiplex approach developed. Low frequency untypeable cassettes are often reported
in large surveys of methicillin-resistant staphylococci. The greatest utility of the
cassette-typing multiplex PCR approaches are their ability to identify the most common
SCCmecs in the predominant MRSA clonal lineages. As will be discussed in proceeding
studies, the multiplex PCR developed by Zhang et al. for MRSA is sufficient to classify
MRSP SCCmec types II-III and VT in predominant clonal lineages ST 71 and ST 68
respectively.45,46
The MRSA SCCmec typing nomenclature has been used for characterization of SCCmec
in other staphylococci. Cassettes are likely similar across species; SCCmec is a MGE
believed to be restricted to staphylococci, and similar cassette types would presumably
be interchangeable between S. aureus, S. pseudintermedius and the CoNS. Three
cassettes associated with S. pseudintermedius have been fully characterized.47,45
Descloux et al. described two cassettes. SCCmec type II-III was identified in 14 of 15
MRSP isolates screened, and SCCmec type VII in a single isolate. SCCmec II-III was found
to be a hybrid of S. aureus SCCmec III and S. epidermidis SCCmec II, and associated with
the most common European MRSP sequence type, ST 71. MRSP SCCmec VII had novel
ccr regions, some similarity to MRSA SCCmec III, but an incomplete mec operon. The
“take-home” message from the Descloux study is that even though the emergence of
methicillin-resistance in S. pseudintermedius is recent, the movement of cassettes
between staphylococci is not a simple transaction whereby the recipient receives an
exact copy from the donor. No MRSP has yet been shown to carry an exact copy of a
MRSA SCCmec. Something about the as yet unidentified mechanism of cassette transfer
between staphylococci causes some level of recombination or deletion. An alternative
explanation could be that direct MRSA to MRSP cassette transfer does not occur, and
the genetic shuffling of the cassettes happens in a reservoir species, such as a
commensal nonpathogenic CoNS.
The third known MRSP SCCmec type (type VT associated with ST 68) was sequenced and
described by Eberlein and Kania at UTCVM, and will be part of the study described in
chapter two.45
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Methods for Sub-Typing S. aureus and S. pseudintermedius

Because SCCmec is mobile, cassette typing alone is insufficient to characterize MRS and
incapable of describing susceptible lineages. Therefore, typing methods have been
developed that focus on areas of genetic variability shared by all isolates. Depending
upon the desired resolution of the bacterial population picture, the following strategies
have been used to type staphylococcal isolates (listed in order from highest to lowest
specificity): pulsed-field gel electrophoresis (PFGE), multiple-locus variable-number
tandem-repeat analysis (MLVA), spa typing, and multilocus sequence typing (MLST).48

Pulsed-Field Gel Electrophoresis

PFGE is among the most discriminative of the typing methods, and is the foundation of
the Center for Disease Control (CDC) Pulsenet initiative for standardized molecular
subtyping of foodborne disease-causing bacteria such Escherichia coli O157:H7,
Salmonella, Shigella, Listeria, or Campylobacter.49 No PCR amplification is required.
Chromosomal DNA is isolated and then digested with a restriction enzyme; for
staphylococci the enzyme most often used is SmaI. Depending upon the number and
location of restriction sites within the genome, a characteristic number of fragments are
produced. Those fragments range from >100KB to <5KB and are separated on agarose
gel by alternating voltage across an electric field. The gel banding patterns are then
assessed by statistical software and assigned a percent similarity relative to one
another.50 Because the frequency of point mutations that can add or delete restriction
sites is high, pulsed-field patterns change relatively quickly through successive bacterial
generations. PFGE is most useful when comparing isolates within a close population,
such as within a single hospital or between a series of patients. The primary
impediment to wide scale use of PFGE is difficulty with reproducibility between
laboratories. It is a labor-intensive process, and the banding patterns vary greatly
depending upon the agarose gel, power supply settings, and analysis software used.
Attempts to standardize PFGE for S. aureus have occurred at the federal level in the
United States and Europe, with its addition to Pulsenet by the CDC and the European
Union Harmony protocol respectively.51,52 No such attempt has been made to
standardize S. pseudintermedius PFGE. Researchers of animal staphylococci typically
use PFGE to add validity to the results of less discriminating typing methodologies (MLST
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or spa typing)45,46,53, or to track closely related isolates in carriage studies between
animals or on different locations of a single animal.54,55

Multilocus Variable Number Tandem Repeat Analysis (MLVA) and spa Typing

MLVA and spa typing fall between PFGE and MLST in their discriminatory ability, and are
therefore used where appropriate for study focus, sample size and cost-effectiveness.
Like MLST, both are PCR-based techniques that have the advantage of being highly
reproducible between facilities. MLVA is a multiplex PCR analyzing the variation in
number of repeats in seven individual S. aureus genes (sspA, spa, sdrC, sdrD, sdrE, clfA,
and clfB).56 In several MRSA studies MLVA was found to be comparable in discriminatory
power with PFGE.48,57 Due to reduced need for expensive single-purpose equipment and
specialized training, MLVA may eventually replace PFGE as the method of choice for CDC
Pulsnet.58-60 Unlike PFGE however, MLVA requires an extensive genus and speciesspecific survey and validation of candidate genes with tandem repeat regions exhibiting
appropriate levels of variability. To date MLVA has not been developed for sub-typing
of S. pseudintermedius.
spa typing is an older single locus technique and subset of MLVA developed by Frenay et
al.; the sequence variation in a highly polymorphic region of the S. aureus protein A is
measured and typed, and statistical software determines relatedness between
isolates.61 Its primary advantage is that only one PCR and sequencing reaction are
required to characterize each isolate. The polymorphic region is classified by number of
24bp repeats and point mutations. Some hospitals use spa typing as their high
throughput baseline MRSA typing modality, monitoring for unusual homogeneous
spikes in spa types that might require PFGE or MLVA for finer characterization. Among
its disadvantages include this need for verification by other methods, and the potential
for mischaracterization of an isolate due to a recombination event that includes spa.62
Within the last two years the spa locus has been characterized for S. pseudintermedius
and used in conjunction with PFGE53 and MLST46 to illustrate clonality in large regional
samples of MRSP. This technique appears promising as a tool to gather information on
sample sizes in the hundreds or thousands, and could be invaluable for an as yet
unperformed comprehensive survey of MSSP and MSRP on a national scale.
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Multilocus Sequence Typing

The resolution provided by PFGE is more in step with the parsing of small differences
between isolates. On the other end of the sub-typing spectrum, for measurement of
bacterial genomic variation through time and over great distances, MLST is the method
of choice.63,64 MLST for S. aureus requires seven individual PCRs (400-500bp) and
sequence analyses in the housekeeping genes: carbamate kinase (arcC), shikimate
dehydrogenase (aroE), glycerol kinase (glp), guanylate kinase (gmk), phosphate
acetyltransferase (pta), triosephosphate isomerase (tpi), and acetyl coenzyme A
acetyltransferase (yqiL).65 S. aureus allelic profiles and STs are assigned by comparing
sequence data for each locus to the MLST repository at http://saureus.mlst.net/.
Variations between loci in different isolates are designated as numbered alleles. A
distinct sequence type is made up of a unique combination of arbitrarily numbered
alleles, e.g. MRSA ST5 has the assigned allelic profile 1-4-1-4-12-1-10.
Essentialness of gene function is the primary selection criteria for MLST loci. All isolates
of a species must have all loci. The loci should be areas of genes that are not prone to
recombination, and should exhibit an average rate of point mutation through time. The
Feil et al. phylogenetic analysis of MLST showed that S. aureus alleles are at least 15-fold
more likely to change by point mutation than by recombination; indicating
recombination at these sites is rare, that they are stable enough to maintain function,
but not too conserved either.63 Sequence differences between isolates at just one locus
indicate a closer phylogenetic relationship than isolates sharing three or fewer alleles.
eBURST analysis is a graphical representation alleles shared between sequence types.
The four loci MLST developed for SIG by Bannoehr et. al has been described previously
in this review. Of the seven gene loci used in the standard S. aureus MLST, only the pta
locus is shared between the two methods.33 S. pseudintermedius MLST has proven
valuable in the examination of isolates collected over large geographic areas and
through many bacterial generations, enabling broader associations than can be made
with other methods. In the proceeding studies MLST will be the primary tool used for
the characterization of the emergence of MRSP in the southeastern United States.
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Quorum-sensing in S. pseudintermedius
As one of the gene loci examined for sequence typing, the accessory gene regulator
(agr) quorum-sensing locus D serves a dual purpose as both a molecular target and a
phenotypic driver of species selection in a mixed species environment. The agrD locus
encodes auto-inducing peptides (AIP) capable of modulating virulence under stress and
in the presence of competing bacteria. These peptides are seven to nine amino acids in
length, and are constitutively expressed and deposited into the surrounding
environment. Once a threshold density of AIP is reached in the immediate bacterial
environment (wound, biofilm, lysosome, etc.) the expression of RNA III is triggered, and
a cascade of virulence-enhancing genes is activated. AIPs of one agr type have been
shown to inhibit the RNA III expression and virulence of staphylococci with a different
agr type. The agr system is thought to have evolved along lines of speciation within the
genus; the assumption being that dominant AIPs have the ability to inhibit the SOS
response in other bacteria within the species, genus, and potentially across genus
boundries.66,67 However, in the case of S. pseudintermedius the four elucidated AIP
variants are shared with S. delphini, and S. intermedius. This suggests that the SIG
shares common quorum-sensing capacity that has been conserved in spite of species
differentiation with tropism towards fairly distinct ecological niches.
SIG isolates encode AIPs structurally different than those of S. aureus. While a majority
of staphylococcal quorum sensing research has focused on interaction among different
types of S. aureus AIPs, some evidence exists that S. aureus AIP may also dampen S.
pseudintermedius virulence expression.66 Little is known about AIP interaction among
different S. pseudintermedius agr types. Recent evidence suggests that expression of
methicillin resistance may be triggered by the RNA III-mediated SOS response.68 These
findings suggest that staphylococcal quorum-sensing cross-reactivity may inhibit the
signally cascade responsible for the expression of virulence and methicillin resistance.

Summary Statement

At its inception the goal of this doctoral project was to clarify the population genetics of
MRSP in the United States. This is largely unexplored territory. Prior to this work MLST
had been performed on only five methicillin resistant isolates from the United States as
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part of the broader SIG multi-country analysis33, but no in-depth analysis of a specific
referral center population had yet been undertaken. To that end a molecular
characterization scheme focusing on both the whole genome and the mecA cassette
was implemented as the foundational study for this project. Methicillin-resistant and
susceptible isolates from the UTCVM collection were analyzed using mecA cassette
sequencing and typing, PFGE, and MLST. Our key findings (Chapter 2) are that the
spread of methicillin-resistance within S. pseudintermedius is clonal (vertical), and that
the southeastern US clone bears a cassette type similar to that of a Taiwanese MRSA
lineage and wholly different than that of the European clonal MRSP.
The next step was to capitalize on this population genetic information. By segregating
isolates according to clonal lineage, applying an external stimulus, and analyzing mecA
expression as a response variable, the effect of genotype was correlated with antibiotic
resistance behavior. Our external stimuli (Chapter 3) include oxacillin over different
lengths of time and different concentrations, as well as quorum-sensing AIPs.
The problem as well as the study of methicillin-resistance in S. pseudintermedius is
relatively new. Defining the movement and activity of resistance genes and the isolates
that carry them has both intrinsic and clinical value. We hypothesize that the expansion
of MRSP is proceeding in a clonal manner, analogous to the early expansion of MRSA.
During this nascent phase of expansion there may be as few as two predominant
regional clones. The over-arching theme for this work is that once characterized, the
clonality of methicillin-resistant staphylococcal lineages can be exploited by linking
genotype with expression characteristics. Clonality allows the molecular researcher to
inform the clinician of conserved characteristics. These discovered characteristics will in
turn inform decisions on antibiotic therapy choice and infection control strategies.
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Abstract
Methicillin resistance encoded by the mecA gene is increasingly observed in
Staphylococcus pseudintermedius. Little is known about the population genetics of
veterinary staphylococci bearing methicillin resistance. The aim of this study was to
determine the relatedness of resistant bacteria and to compare them with methicillinsusceptible isolates. Multilocus sequence typing (MLST) and pulsed-field gel
electrophoresis (PFGE) fragment profiling were performed on methicillin-resistant S.
pseudintermedius (MRSP) and methicillin-susceptible S. pseudintermedius (MSSP)
isolates obtained from canine samples submitted to the veterinary teaching hospital
bacteriology service between 2006 and 2008. Multilocus sequence typing detected 20
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different sequence types, 16 of which were not previously described. Methicillinresistant isolates were predominantly ST68, possessed the Staphylococcus aureusassociated staphylococcal chromosomal cassette mec (SCCmec) type VT and fell within
the largest PFGE cluster; whereas methicillin-susceptible strains were more genetically
diverse. This suggests that most methicillin resistance within the population of isolates
tested originated from a single source, which has persisted and expanded for several
years.

Introduction

Coagulase-positive hemolytic Staphylococcus species, particularly S. pseudintermedius,
are associated with clinically important infections in dogs. The prevalence of MRSP in
dogs is rising. Prior to 1999 reported frequencies of MRSP isolates from dogs were low
(<5%); in several surveys from the 1980s, all veterinary staphylococcal isolates tested
were susceptible to methicillin.5,36,37 An increasing number of multidrug-resistant
isolates from dogs have been associated with MRSP.8,35
Little is known about the population genetics of MRSP. Epidemic MRSA lineages have
emerged through horizontal transfer of SCCmec into successful methicillin-susceptible
lineages. Once established, MRSA clonal complexes typically dominate specific
geographic regions.69 It is likely that this has occurred with MRSP, and that S.
pseudintermedius gained SCCmec through horizontal transmission within recent
history.33
The purpose of this study was to use standard MLST, PFGE, and SCCmec typing
techniques to explore relationships among a collection of geographically linked, MRSP
and MSSP isolates.

Materials and Methods

Bacterial strain selection
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S. pseudintermedius isolates were obtained from clinical samples submitted to the
University of Tennessee College of Veterinary Medicine Clinical Bacteriology Laboratory.
A total of 60 non-duplicate isolates from dogs were arbitrarily selected from nine
groups, and then were sorted by year of isolation and by presumptive categories of
relative in vitro susceptibility to oxacillin. Samples included 20 from 2006, 21 from 2007,
and 19 from 2008. Isolates with oxacillin zone diameters equal to or less than 10 mm
were categorized as high-level-resistant (n=19), isolates with zone diameters from 11 to
17 mm were categorized as low-level-resistant (n=21) and isolates with zone diameters
equal to or greater than 18mm were categorized susceptible (n=20).70 Each group
contained six to eight isolates. Bacterial isolation and identification procedures were
those routinely used in the laboratory as previously described.8 Isolates phenotypically
identified as “S. intermedius” were presumed to be S. pseudintermedius. Species
identity of S. pseudintermedius was confirmed by partial 16S rRNA and pta gene
sequencing associated with the MLST process (Bannoehr et al., 2007). The type strain of
S. intermedius isolated from a pigeon (ATCC 29663) and S. pseudintermedius (ATCC
51874, isolated from a dog and originally designated S. intermedius) served as reference
strains for this study.

DNA isolation
Isolates were grown on blood agar plates overnight at 37°C and bacteria derived from a
single colony were suspended in 0.5 ml of TE buffer mixed with an equal volume of glass
beads. DNA was extracted by cell disruption following pulsed vortexing.

SCCmec typing and characterization

Multiplex PCR designed for characterization of SCCmec types I-V in S. aureus was used
to characterize all MRSP cassette types.43 A representative ST68 was chosen for full
cassette sequencing using a primer walking strategy. Sequences were obtained from
PCR products at the University of Tennessee Molecular Biology Resource Facility.
Overlapping contiguous sequences were aligned using DNA analysis software (Lasergene
Sequence Manager). PCR primers for the detection of the ccrC2 sequence in SCCmec
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type VT were used to confirm the similarity of the type V cassettes associated with ST68
isolates.71

Multilocus Sequence Typing

Oligonucleotide primers specific for tuf, mecA, 16s rRNA, cpn60, pta and agrD genes
were designed in previous studies.33,72 PCR was performed as previously described.33
PCR products of expected sizes were treated to destroy single-stranded DNA (ExoSap-IT,
USB Corp., Cleveland, OH) and submitted to the University of Tennessee Molecular
Biology Resource Facility for DNA sequencing. PCR primers were used for direct DNA
sequencing of PCR amplification products. STs were assigned using the method
established by Bannoehr et al. Briefly, this involved matching pta, cpn60, tuf, and agrD
sequences determined from study isolates with corresponding reference sequences
available in GenBank. Designations for each allele correspond to a code used to assign
ST. For alleles that were not previously reported, new STs were assigned beginning
sequentially and following the previous designations.

Pulsed-field Gel Electrophoresis

Pulsed-field gel electrophoresis (PFGE) was performed using the protocol described by
McDougal et al. with minor modifications.52 Briefly, a single colony from each
catalogued isolate was grown aerobically on a blood agar plate for 24 hours at 37°C.
From the plate a cell suspension in saline was made to a reading of 0.50 using the
MicroScan turbidity meter, (Dade Behring Inc., Deerfield, IL). Plugs were formed in
disposable ~ 100 μl molds by mixing equal amounts of cell suspension with 1.2%
SeaKem Gold agarose (FMC, Rockland, Maine). Formed plugs where incubated in a
solution of TE buffer (2.8 ml, 10 mM Tris HCl, 1 mM EDTA *pH 8+), Lysozyme (200 μl, 10
mg/ml) and Lysostaphin (20 μl, 10 mg/ml) for two hours at 37°C. The previous solution
was poured off. The plugs were then incubated in 5 ml of cell lysis buffer (1M Tris HCL,
0.5M EDTA, 10% Sarcosyl solution, Sterile Type 1 water) and 10U proteinase K at 54°C
for two hours in a shaking water bath. Plugs were washed twice with Type 1 water for 5
minutes and four times with TE buffer for 15 minutes each. All washes took place in the
54°C shaking water bath. Plugs were cut in half and digested using 2 μl BSA, 20 μl of
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buffer 4 New England BioLabs (NEB, Ipswich, MA), 40U SmaI (NEB) and 176 μl of Type 1
water per section. Digestion was achieved over a minimum of two hours in a 25°C water
bath. Restriction fragments were separated by PFGE using a CHEF Mapper (Bio-Rad
Laboratories, Hercules, CA). Running conditions consisted of 6.0 V/cm, optimized for
separation of 30 kb low molecular weight to 600 kb high molecular weight fragments,
and 40 second initial switch time and 45 second final switch time for 18 hours. Isolates
unable to elicit a distinct band pattern with SmaI were restricted with ApaI using the
same protocol.
Gels were stained with ethidium bromide, destained in deionized water and the images
were digitally captured using a GelDoc 2000 UV transilluminator and Quantity One
software (Bio-Rad Laboratories, Hercules, CA). The Salmonella Braenderup H9812
global standard was used for gel normalization using BioNumerics software (Applied
Maths, Sint-Martens-Latem, Belgium) and banding patterns were compared in the
normalized view using PulseNet E. coli scripts. PFGE DNA fingerprint types were
assigned using the Tenover criteria.73

Results
SCCmec typing and characterization

Identical mecA gene sequences were obtained from all methicillin-resistant strains,
matching S. pseudintermedius (accession no. AM 904732) and S. aureus (accession no.
EU 790490). Thirty-seven of 38 MRSP SCCmec types characterized via multiplex PCR43
corresponded with S. aureus type V. Thirty-seven of 38 MRSP SCCmec types
characterized via ccrC2 PCR71 corresponded with S. aureus SCCmec type VT. A single
MRSP isolate was untypeable by either method.
Sequence of a representative type V S. pseudintermedius cassette (GenBank accession
no. FJ544922.1) was homologous, with the exception of one deleted section of a gene,
to SCCmec type VT (accession no. AB462393) first described in a community-associated
methicillin-resistant S. aureus (CA-MRSA) from Taiwan.74
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Multilocus Sequence Typing

A total of 600 fragment sequences including forward and reverse reactions,
representing five genes (16S rRNA, pta, tuf, cpn60 and agrD) from 60 strains, were
analyzed. 16S rRNA gene sequences were identical among all isolates in this study and
matched those reported for S. pseudintermedius (accession no. EU157264).
Thirty-seven of 38 methicillin-resistant isolates belonged to ST68, while a single
methicillin-resistant isolate, from 2007 and phenotypically classified as low-level
resistant, had a novel ST pattern (TABLE 2). No apparent association was found
between oxacillin disk zone diameter for methicillin-resistant isolates and ST. Fifteen of
the novel sequence types were detected among 19 of the 22 methicillin-susceptible
strains examined.
The pta sequences examined had five different alleles (TABLE 1). The sequences of four
alleles were identical to S. pseudintermedius pta sequences previously reported.33 A
novel pta sequence, representing a fifth allele, with a single nucleotide difference, was
identified (accession no. FJ170820).
Eight variable sites were detected in cpn60 sequences and were identical to those
reported previously.33 A novel cpn60 sequence was found in the same isolate that
contained a novel pta sequence (accession no. FJ170819).
One variable site occurred in tuf sequences with two alleles. These sequences were
identical to S. pseudintermedius sequences reported previously.33
agrD sequencing revealed the presence of the four previously described alleles and
known agrD (auto-inducing peptide) types.33 MRSP ST68 was type IV; as were eight of
the MSSP isolates. Type ІІІ was found in six of 20 MSSP isolates, as well as in the novel
MRSP ST105. Type II was found in seven of 20 MSSP isolates. Type I was found in only
one novel susceptible strain.

Pulsed-field Gel Electrophoresis

A dendrogram of percent similarity, calculated with Dice coefficients revealed a single
major cluster of methicillin-resistant isolates containing all 37 that were ST 68 (FIGURE
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1). Within the pulsed-field cluster that contained ST 68, 22 subtypes were identified
with 79.7% similarity. Three ST68 isolates, representing two subtypes, were positioned
outside the 80% cutoff for close relatedness by the Tenover criteria.73

The single MRSP isolate with the novel sequence type ST105, and containing an SCCmec
type other than MRSA SCCmec type VT, exhibited a pulsed-field pattern unrelated to any
other isolates tested.
All methicillin-susceptible isolates exhibited unique pulsed-field patterns. Three
susceptible groups were closely related – one group with three isolates, two groups with
two isolates each. All isolates within >80% similarity groupings, other than the group
containing all ST68 isolates, had distinct sequence types.

Discussion
MLST and PFGE are both highly discriminatory methods for characterizing bacterial
isolates.52,65 In contrast to single locus classification systems, whole genome or
multilocus identification methods provide more clarity concerning bacterial relatedness
and can be applied to both susceptible and resistant strains. MLST was used in a multicountry survey to determine the population genetic structure of S. pseudintermedius;
however, in that study only five methicillin-resistant samples from the United States
were included.33 Other recent surveys using PFGE have demonstrated relatedness
amongst MRSP isolates in small sample sizes from specific geographic regions.53,75
Results from our study add strength to the horizontal transmission and geographic
clonal dissemination model of methicillin-resistant staphylococci.69 Our most notable
finding is that 37 of 38 methicillin-resistant isolates in this regional sampling were of a
single sequence type, ST68, and demonstrated relatedness in pulsed-field type. This
finding parallels the Bannoehr European sample wherein seven methicillin-resistant
isolates from dogs with clinical infections in Germany and Sweden were also from a
single clone, ST71, while a single canine commensal isolate from Sweden was of a
different clonal group, ST69.33
The 37 ST68 isolates appeared to carry a type V cassette when tested with the S. aureus
multiplex PCR typing described by Zhang et al., but DNA sequencing of the cassette
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TABLE 2.1. Allelic profiles and agrD types of novel S. pseudintermedius sequence types (ST) isolated from dogs compared to the predominant MRSP
ST68.

21

TABLE 2.2. Nucleotide sequence variations and alleles in five housekeeping genes and mecA of S.
pseudintermedius.
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FIGURE 2.1. Dendrogram based on pulsed-field gel electrophoresis analysis of 60 S. pseudintermedius.
Shaded rows represent isolate groupings that are methicillin-resistant and contain the mecA gene.
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revealed that it was a truncated version of SCCmec type VT.74 This cassette was first
reported in a successful multidrug-resistant CA-MRSA lineage from Taiwan, and has
recently been reclassified as SCCmec type VII.71 SCCmec types II, III and V were
previously described in S. pseudintermedius using multiplex PCR procedures used in the
present study, and the complete cassette sequence from two isolates that were
characterized as having type III cassettes by the multiplex PCR method revealed a new
hybrid sequence that has been called type II-III.47 The SCCmec cassette associated with
the ST105 isolate has not yet been characterized, as this cassette is untypeable using the
methods employed for this study. However, the presence of mecA in ST105 has been
confirmed using PCR, and the ST105-associated cassette has been differentiated from
the ST 68-associated cassette by applying primers used for type V sequencing. The
circumstances and mechanism by which the ST68 S. pseudintermedius lineage in the
present study acquired a cassette associated with a disease-causing human S. aureus
lineage are unknown. The finding implies, however, that inter-species transfer of
antibiotic resistance between human and canine pathogens may have occurred.
A single methicillin-resistant isolate with a different and novel ST and pulsed-field type
was found – ST105. Only five MRSP sequence types have been described – STs 29, 68,
69, 70 and 71.33 ST 105 differed from ST 68 at three alleles, indicating a distant
phylogenetic relationship. This genetic dissimilarity supports the independent
acquisition of mecA by each lineage.33 Sequence type 105 may represent an emerging
MRSP lineage, or it may be a transient cassette carrier that will fail to successfully
compete with the predominant ST68. Collectively these data indicate that clonal
expansion, regional selection and maintenance of the more successful clone have
occurred.
Only three previously reported MSSP sequence types, STs 15, 17 and 19, were identified
from one isolate each. Sixteen novel sequence types were identified among clinical
isolates of S. pseudintermedius from dogs; all but one were from methicillin-susceptible
isolates. Among methicillin-susceptible strains in our study 19 of 22 (86%) belonged to
novel STs and all had distinct pulsed-field patterns. This broad range of clonal diversity
amongst MSSP contrasts with the limited number of MRSP lineages seen in the United
States and Europe, where ST68 and ST71 predominate respectively.33
It is not known if the apparent tendency of antibiotic resistance cassettes to remain in
so few lineages is due to the rarity and relative difficulty of cassette transfer, or is a
function of the ability of an MSSP lineage to successfully incorporate the mobile genetic
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element into its genome. Based upon the variety of MSSP isolates observed, this
question warrants further investigation.
In this study, we report an association between ST 68, PFGE type and SCCmec type VT in
contemporary clinical isolates of S. pseudintermedius from dogs in the southeastern
United States. The known genetic diversity among canine isolates of S.
pseudintermedius was increased by the discovery of 16 novel sequence types and a
strain that contained novel sequences for both pta and cpn60 genes. Regional, national
and global sharing of molecular surveillance data generated for MRSP strains through
the use of techniques such as single and multi-locus gene sequencing and PFGE will help
determine the epidemiological significance and patterns of spread for these newly
emerging strains.
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Abstract
Regional clones of methicillin-resistant Staphylococcus pseudintermedius (MRSP)
affecting veterinary clinical practice have recently been identified in Europe and North
America – multilocus sequence types (MLST) 71 and 68 respectively. One notable
difference between the two clones is a deletion in the mecI/mecR1 regulatory apparatus
of the staphylococcal chromosome cassette (SCCmec) carried by ST68. This deletion in
analogous methicillin-resistant Staphylococcus aureus (MRSA) results in more
responsive and greater expression of the mecA encoded penicillin-binding protein 2a, a
characteristic associated with community-acquired MRSA lineages. The aim of this
study was to characterize mec and bla regulatory apparatuses in MRSP. Seventeen wildtype S. pseudintermedius isolates representing nine methicillin-resistant lineages were
screened via PCR for the presence of the repressors blaI and mecI and sensors blaR1 and
mecR1. The bla and mec operons for each isolate were sequenced and compared for
homology between the repressor open-reading frames (ORF), sensor ORFs, and mecA
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promoter regions. A real-time reverse transcriptase PCR expression assay was
developed, validated and applied to nine isolates determining the effect of low-level
oxacillin induction and quorum-sensing reporter RNAIII on mecA transcript production.
Comparisons of the induction of mecA expression were made between isolates with a
full regulatory complement (mecI/mecR1 and blaI/blaR1) and those with truncated
and/or absent regulatory elements.

Introduction
Staphylococcus pseudintermedius on dogs is analogous to S. aureus on humans, acting
as both normal flora and opportunistic pathogen. It is the primary cause of pyoderma,
the most common dermatologic disease seen in dogs, and is also frequently associated
with wound, urinary tract and surgical site infections.4 The first finding of S.
pseudintermedius bearing the mecA methicillin resistance gene occurred in 1999.5 In the
decade since its discovery, methicillin-resistant S. pseudintermedius (MRSP) has become
increasingly common, reaching prevalence as high as 30% in studies of referral center
isolates.6,35,76
Recent multilocus sequence typing (MLST) studies have established geographic clonal
emergence of two MRSP lineages.33,45,77,46 Sequence type 71 predominates in Europe,
bears the hybrid resistance cassette SCCmec II-III, and has acquired resistance to all
clinically useful veterinary antimicrobial drugs expect lincosamides.77,47 Whereas ST68 is
the most common MRSP sequence type in the United States and Canada, bears SCCmec
VT, and has acquired resistance to all clinically useful veterinary antimicrobial drugs
except chloramphenicol.45,77
As is the case with MRSA, methicillin resistance in S. pseudintermedius results most
commonly from the acquisition of the mecA gene encoding penicillin-binding protein 2a
(PBP2a). PBP2a contains an altered beta-lactam binding site, preventing antibiotics of
that class from disrupting gram-positive cell wall metabolism. In addition to synthetic
beta-lactam resistance mediated by mecA, all isolates characterized as ST68 and ST71
have thus far also demonstrated penicillin resistance through blaZ-encoded betalactamase.33,45,77,46
The controlling mechanisms for bla and mec systems are different from other bacterial
signal transduction pathways in that they lack a kinase-based system for signal
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transduction.78 Instead they are modulated by two-component systems consisting of the
analogous repressors mecI and blaI and sensors mecR1 and blaR1 respectively. BlaR1
and MecR1 represent transmembrane spanning and signal transducing proteins.
Acylation of BlaR1/MecR1 subsequent to external interaction with beta-lactam
antibiotics is followed by their autoproteolytic cleavage on the cytoplasmic side of the
cell membrane. This separated intracellular portion of BlaR1/MecR1 travels to the
bacterial chromosome and removes its cognate repressor BlaI/MecI via proteolysis.
Once the repressor dissociates from its promoter-region binding site, transcription of
the blaZ/blaR1/blaI and mecA/mecR1/mecI genes begins. The structure and function of
MecI and BlaI are similar but not identical; they share approximately 60 percent
sequence homology.79,80 The repressors can act interchangeably, binding to the
promoter-operator region of either the blaZ or mecA operon. However, mecA induction
occurs only through the cognate sensor; the intracellular peptidase portion of
transmembrane BlaR1 only has activity on BlaI, and MecR1 only cleaves MecI.81
The mec promoter region consists of ~100 nucleotides situated between the mecA and
mecR1 open reading frames. The mec operator is a subset of the promoter region and is
a 30 bp palindrome covering mecA -10 and mecR1 -35 promoter sequences. Within the
palindrome lies two 4 bp inverted repeats (TACA/TGTA) that serve as binding motifs for
the repressors MecI and BlaI.79,82 Others have shown that mutations within this
operator region can affect the ability of the repressors to bind appropriately, and
thereby account for differences in mecA expression.83
In MRSA it has been demonstrated that mecI/mecR1 and blaI/blarR1 configuration has a
significant impact on the speed and character of mecA induction. While a majority of
epidemic strains are blaZ positive with functional blaI/blaR1 elements, many have
deletions of mecI and varying levels of truncation in mecR1; the completeness of the
mecA operon has become a defining characteristic of MRSA SCCmec type. Clinical MRSA
isolates as well as transformed laboratory strains with only mecI/mecR1 induced mecA
expression more slowly than those with complete blaI/blaR1 and without functional
mecI/mecR1. Those isolates with both regulatory apparatuses, with both MecI and BlaI
available for promoter binding, appear to be even more tightly controlled.84,85
Methicillin resistant staphylococcal isolates cured of their SCCmec have improved
growth rates relative to their mecA containing counterparts.86 This discovery and the
presence of some level of bla and mec regulatory apparatus in all successful and widelydisseminated methicillin-resistant lineages suggests a metabolic cost is associated with
unregulated expression of mecA. The exact benefit derived from differing levels of
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mecA control is unclear. However, a recent historical examination of antibiotic
resistance in S. aureus by Chambers and DeLeo demonstrates four waves in MRSA
evolution beginning with blaZ in response to penicillin therapy, followed by three mecA
acquisitions with differing levels of mecA control. The initial Iberian clone and
subsequent healthcare-associated MRSA lineages bearing SCCmec types II and III have
functioning mecI and mecR1; whereas more recent community-associated MRSA bear
cassettes with mecI deletions and rely on blaI/blaR1 to regulate mecA expression.87-89
In addition to mec-specific regulatory genes, staphylococci also carry the more
generalized accessory gene regulator (agr) complex, which produces one of four
potential quorum-sensing auto-inducing peptides (AIP) characteristic of its lineage. The
peptides are seven to nine amino acids in length, and are constitutively expressed and
deposited into the surrounding environment by the bacteria. Once a threshold density
of AIP is reached, the expression of RNAIII is triggered, and a cascade of potential
virulence-enhancing genes is activated.66 Recent expression studies with MRSA have
suggested that mecA may fall under the broader control of agr.68 The agr locus of
MRS(P)I has been described67, but its relationship to mecA has yet to be investigated.
The emergence of MRSP is recent relative to that of MRSA and thus far restricted to two
known geographic clones bearing distinct cassette types. These SCCmec types differ in
the mecI/mecR1 regulatory apparatus of mecA, and are analogous with the two types of
cassette structures found in HA and CA-MRSA. Here we inventory the
mecA/mecI/mecR1, blaZ/blaI/blaR1, and mecA promoter region status of both major
and minor MRSP lineages and apply a real-time RT-PCR mecA expression assay to
correlate regulatory gene presence or absence with speed and abundance of transcript
production.

Materials and Methods

Bacterial Isolate Selection and Identification

S. pseudintermedius isolates were obtained from clinical samples submitted to the
University of Tennessee College of Veterinary Medicine Clinical Bacteriology Laboratory
as well as from European and North American collaborators through previous clonality
studies.45,77 A total of 17 non-duplicate isolates from dogs were selected representing
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nine MLST lineages associated with methicillin resistance as an initial pool to screen for
blaI/blaR1 and mecI/mecR1 variation. Bacterial isolation and identification procedures
were those routinely used in the laboratory as previously described.8 Isolates
phenotypically identified as ‘‘S. intermedius’’ were presumed to be S. pseudintermedius.
Multilocus sequence typing provided definitive species identity of S. pseudintermedius
with partial 16S rRNA and pta gene sequencing. The type strain of S. intermedius
isolated from a pigeon (ATCC 29663) and S. pseudintermedius (ATCC 51874, isolated
from a dog and originally designated S. intermedius) served as reference strains for this
study.

DNA Extraction

Isolates were grown on blood agar plates overnight at 37°C and bacteria derived from a
single colony were suspended in 0.5 ml of TE buffer mixed with an equal volume of glass
beads and vortexed for ten minutes. Supernantant in the centrifuged cell lysate was
used as template DNA for traditional PCR amplification of mec and bla regulatory genes.

PCR Primers and Conditions

Olignucleotide primers specific for S. pseudintermedius mecA promoter and blaI/blaR1
were based upon MRSP SCCmec type V cassette (GenBank accession no. FJ544922.1)
and unpublished ST68 genomic data respectively (TABLE 3.1), and designed using IDT
SciTools application (Integrated DNA Technologies, Coralville, IA).90 Primers for
mecI/mecR1 were adapted from Hiramatsu et al.91 Primers for RNAIII were adapted
from Sung et al.67 Conventional PCR was performed using the following parameters: 95º
for 90 seconds followed by 35 cycles of 55° for 30 seconds, 68º for 120 seconds, and 94º
for 30 seconds.
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TABLE 3.1. Primers used with conventional PCR.
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Sequence analysis

PCR products of expected sizes were treated to destroy single-stranded DNA (ExoSap-IT,
USB Corp., Cleveland, OH) and submitted to the University of Tennessee Molecular
Biology Resource Facility for DNA sequencing. PCR primers were used for direct DNA
sequencing of PCR amplification products. Open reading frames for blaI, blaR1, mecI,
mecR1 and mecA promoter were compared between isolates using Lasergene® SeqMan
Pro software (DNASTAR, Inc., Madison, WI).

MLST and PFGE

Genetic diversity of S. pseudintermedius was determined by MLST of five genes (16S
rDNA, tuf, cpn60, pta and agrD) and by SmaI-PFGE as previously described.33,45 MLST
sequences were compared with allele sequences present in the NCBI nucleotide
database in order to determine the allele number. Sequence type numbers were
assigned using the key table for MLST typing of S. intermedius group isolates. New
sequence types were assigned by the curator, Vincent Perreten
(vincent.perreten@vbi.unibe.ch).77

Bacterial Growth and RNA Extraction – Time Point mecA Expression Assay

For each isolate a 5 ml vial of BBL™ Trypticase™ soy broth (TSB, Becton, Dickinson and
Co., Sparks, MD) was inoculated with a single colony grown on blood agar and then
incubated overnight at 37°C and 225 rpm. Fifty microliters of overnight growth was
used to inoculate four additional 5 ml soy broth vials, which were subsequently
incubated at 37°C and 225 rpm for four hours. Oxacillin (Sigma Aldrich, St. Louis , MO)
was added to a single vial at four, two, and one hours prior to RNA extraction. The
oxacillin concentration was 0.01 µg/ml for all induction vials; this concentration was
chosen because in preliminary testing it represented the minimum amount at which the
type strain ST68 (06-3228) reproducibly increased mecA expression greater than fivefold over baseline. One of the four vials was incubated without oxacillin induction to
serve as the baseline for mecA expression.
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Following four hours of growth RNA was extracted using UltraClean™ Microbial RNA
Isolation Kit (MO BIO Laboratories, Carlsbad, CA). Contaminating DNA was removed
using TURBO DNA-free™ DNase (Ambion, Inc., Austin, TX). The resulting RNA template
was stored in aliquots suspended in DNase RNase free water at -80.0°C.

Bacterial Growth and RNA Extraction – Oxacillin Curve mecA Expression Assay

For each isolate a 5 ml vial of BBL™ TSB (Becton, Dickinson and Co., Sparks, MD) was
inoculated with a single colony from growth on blood agar and was then incubated
overnight at 37°C and 225 rpm. Fifty microliters of overnight growth was used to
inoculate seven additional 5 ml soy broth vials, which were incubated at 37°C and 225
rpm for four hours. Oxacillin (Sigma Aldrich, St. Louis , MO) was added to six vials in a
fivefold dilution series at concentrations 0.0016, 0.0080, 0.0400, 0.2000, 1.0000 and
5.0000 µg/ml. One of seven vials was incubated without oxacillin induction to serve as a
mecA expression baseline.
Following four hours of growth RNA was extracted using UltraClean™ Microbial RNA
Isolation Kit (MO BIO Laboratories, Carlsbad, CA). Contaminating DNA was removed
using TURBO DNA-free™ DNase (Ambion, Inc., Austin, TX). Resulting RNA template was
stored in aliquots suspended in DNase RNase free water at -80.0°C.

Realtime RT-PCR – Measurement of mecA Induction and Copy Number

Primers and probes (TABLE 3.2) for target mecA and endogenous control 16S were
designed using Primer Express® software and constructed as custom TaqMan® Gene
Expression Assays (Applied Biosystems, Foster City, CA). Applied Biosystems reagents
TaqMan® 2X Universal PCR Master Mix and Multiscribe™ Reverse Transcriptase were
used in a 10 µl one-step RT-PCR protocol in the following amounts per well: 5.00 µl Taq
polymerase, 2.75 µl water, 1.50 µl template RNA, 0.50 µl primer and probe mix, and
0.25 µl reverse transcriptase. Each sample was analyzed in triplicate. Template RNA
was diluted either 1 to 100 or 1 to 1000. All time point or differing oxacillin
concentration samples for each isolate were analyzed together in one run per isolate on
a 48-well plate in a StepOne™ Real-Time PCR System (Applied Biosystems, Foster City,
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mecA
forward
reverse
probe

5’-GGCATGAGTAACGAAGAATATAATAAATTAACCG-3’
5’-TTGAGTTGAACCTGGTGAAGTTGT -3’
5’-CTGCTCAACAAGTTCC-3’

16S
forward
reverse
probe

5’-CCCTTGAACTTAGTTGCCATCATTC-3’
5’-CACCTTCCTCCGGTTTGTCA-3’
5’-CCGGCAGTCAACTTA-3’

mecA with T7 promoter
forward
5’-TAATACGACTCACTATAGGGGCATGAGTAACGAAGAATATAATAAATTAACCG-3’
reverse
5’-TTGAGTTGAACCTGGTGAAGTTGT-3’
RNAIII
forward
reverse
probe

5'-AGTAAGGAAAAAGATTCTAACAAATACTT-3'
5'-GCAGCAGATATCATTAGCACAATCG-3'
5'-CTGTTTCTGCGATAAGTTT-3'

TABLE 3.2. Realtime RT-PCR primers and probes.
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CA). Thermocycler parameters were as follows: 48°C for 30 minutes, 95°C for 10
minutes, 40 cycles: 95°C for 15 seconds and 60°C for 1 minute.
The mecA mRNA for standard curve analysis was produced by adding a T7 promoter to
the sequence of the mecA forward primer utilized in the real-time assay (TABLE 3.2).
This primer coupled with the reverse primer from the real-time assay was applied to
genomic DNA of 06 3228 under the following thermo-cycling conditions: 95º for 90
seconds followed by 35 cycles of 55º for 30 seconds, 68º for 120 seconds, and 94º for 30
seconds. The resulting T7 mecA DNA template was electrophoresed on an 0.8% agarose
gel. The single band 117 bp product was excised and extracted (QIAquick® Gel
Extraction Kit, Germantown, MD). Following manufacturer’s recommendations for DNA
<500 bp in length, 1.0 µg served as template in a 16 hour transcription reaction
(MEGAscript® T7, Ambion Inc., Austin, TX). The 97 bp RNA product was treated with 4 U
TURBO DNase (Ambion Inc., Austin, TX) at 37ºC for 30 min, and filtered to remove all
non-RNA elements (MEGAclear™, Ambion Inc., Austin, TX). The copy number per µl was
calculated using µg/ml measurements from a NanoDrop 3300 fluorospectrometer
(ThermoScientific Inc., Wilmington, DE). The transcripts were used to create standard
curves for absolute quantitation of mecA mRNA transcripts isolated from the samples.
The numbers of RNA copies were estimated based on the molecular weights of the RNA
standards and the RNA concentrations. Ten-fold serial dilutions were prepared, and
aliquots of each dilution were stored at –80°C and used only once.

The efficiency of the real-time RT-PCR assay to amplify the mecA standard mRNA was
evaluated with the equation: Efficiency = [10(–1/slope)] – 1.92 Slope is a value derived from
the constructed standard curves. To insure equal amplification efficiency in tested
isolates, four ten-fold serial dilutions of RNA extracted from wild-type MRSP were tested
against the standard curve. The efficiencies were comparable. Quantitiation of mecA
copy number was calculated by transforming Ct values to the relative number of RNA
molecules. The quantity of cDNA for each experimental gene was normalized to the
quantity of 16S cDNA in each sample as previously described.93
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Estimation of 16S Endogenous Control Copy Number

Multiple 16S genes appear in the bacterial chromosome of S. aureus, usually ranging
from six to eight copies.94 To insure that mecA transcript measurement was not
compromised by significant disparities in 16S copy number between S.
pseudintermedius sequence types, comparison of 16S DNA relative to that of single copy
mecA was made using real-time PCR.
Genomic DNA from one isolate each representing STs 68, 71, 73, and 116 was extracted
using UltraClean™ Microbial DNA Isolation Kit (Mo Bio Laboratories, Inc., Carlsbad, CA).
The purified DNA amount was measured and adjusted to equal µg/ml concentrations.
Real-time PCR was performed as previously described without reverse transcriptase
using 16S rRNA and mecA primers and probes. Based upon the assumptions that both
primer sets are equally efficient (achieved with validation for ∆∆Ct mecA expression
assay) and that mecA is represented in the genome as a single copy, 16S rRNA Ct values
arising before that of mecA indicate that multiple 16s genomic copies are present. Fold
change calculations can then show 16s copy number relative to that of mecA.

RNAIII Expression in Conjunction with mecA Expression

For each isolate a 5 ml vial of BBL™ TSB (Becton, Dickinson and Co., Sparks, MD) was
inoculated with a single colony from growth on blood agar and was then incubated
overnight at 37°C and 225 rpm. Fifty microliters of overnight growth was used to
inoculate five additional 5 ml soy broth vials, which were incubated at 37°C and 225 rpm
for one, three, five, seven, and nine hours. RNA extraction and realtime RT-PCR was
performed as previously described using mecA and RNAIII specific primers and probes.
Each reaction was performed in triplicate with one primer set per well. ∆∆Ct foldchange over baseline comparisons were made against the one hour measurement.
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Statistical Analysis

A mixed model ANOVA (SAS, version 9.2, SAS Institute Inc, Cary, NC) was used to
estimate the effect of sequence type (68 verses 71) and time on inverse log of mecA
expression. Isolate, sequence type and time were modeled as class variables and isolate
was included as a random factor in the model. Independent variables sequence type,
time and the interaction of sequence type and time were evaluated for an effect on the
dependent variable log of mecA copy number. A second and similar model was used to
assess the effect of blaI regulation alone verses functional mecI regulation, time and the
interaction of blaI and mecI status on the inverse log of mecA copy number. In the
second model isolate, gene status (blaI vs. mecI) and time were included as class
variables. A multiple range test according to the method of Tukey was used to adjust
for multiple comparisons in both models. The fit of the both models to the data was
evaluated by assessing the degree to which the residuals from the models fit a normal
distribution using the Shapiro-Wilk test statistic. An a priori adjusted p-value of < 0.05
was used to determine statistical significance for all tests.

Results

Screening for mecA, mecI, mecR1, blaZ, blaI, and blaR1 Initial mecA Expression Assay

Twelve isolates representing nine sequence types comprised the initial mec and bla
regulatory element survey of MRSP isolates (TABLE 3.3). All were phenotypically
methicillin resistant and confirmed mecA positive. All but one isolate (ST73) were
phenotypically beta-lactamase positive and contained blaZ, blaI and blaR1 elements.
Sequence types 71 and 73 were the only MRSP backgrounds that screened positive for
the repressor mecI. The two ST71 isolates (one European and one North American)
contained both repressors mecI and blaI. No American isolates other than NA18 (ST71)
had a complete mecI sequence.
The initial twelve isolates chosen for mec and bla regulatory element detection were
grown with and without 0.01 µg/ml oxacillin for four hours and the relative level of
mecA transcript production was measured by realtime RT-PCR using the ∆∆Ct method
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TABLE 3.3. Isolates used in study – presence/absence of mec and bla elements. Shaded rows represent isolates that were further characterized by time
point mecA expression assay.
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(FIGURE 3.1). Error bars indicate the standard error of the mean and relative
quantitation of mecA expression is represented on a log scale.
Those isolates screening positive for blaI only (represented by North American STs 26,
68, 69, 105, 116, and 118) increased mecA expression to a greater extent than the ST71s
containing both mecI and blaI. Sequence type 73 bearing mecI alone increased mecA
expression at four hours to a level similar to that of the blaI-only isolates.

Sequence Type Selection for Further Analyses

Based upon the initial mecA expression assay and the presence or absence of mec and
bla elements, STs 73 and 116 were selected to contrast the regulatory apparatuses of
the predominant geographic clones ST68 (North America) and ST71 (Europe). Sequence
type 73 lacks a bla operon but has a complete mec operon resulting in a -blaI/-blaR1
+mecI/+mecR1 configuration with regard to mecA expression control. Whereas ST68
has +blaI/+blaR1 -mecI/mutmecR1 (absent mecI and mutation/truncation of mecR1) and
ST71 has both complete repressor/sensor systems in +blaI/+blaR1 +mecI/+mecR1.
Sequence type 116 was chosen because the original blaI 1 forward and reverse primers
(TABLE 3.1) were unable to elicit a PCR product. A region internal to the previous blaI
target was amplified using blaI 2 forward and reverse primers. Sequence type 116 blaI
genomic sequence compared with that of STs 68 and 71 had multiple nucleotide and
translational dissimilarities (FIGURE 3.2). Therefore ST116 was classified as
mut
blaI/+blaR1 -mecI/+mecR1 (the mutation designation for blaI is relative to that of STs
68 and 71).
Sequence types 73 and 116 contain only one known characterized isolate each.
However, additional wild-type clinical ST68 (n=3) and ST71 (n=2) isolates were added to
subsequent analyses to show reproducibility of mecA expression within sequence type
background. In total four North American ST68s, three European ST71s, and one each
of STs 73 and 116 were fully characterized by MLST, PFGE (FIGURE 3.3), mec and bla
regulatory gene sequencing, and mecA expression analysis at four time points.
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FIGURE 3.1. Relative mecA expression measured with and without 0.01 µg/ml oxacillin induction at 4.0 hours growth.
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FIGURE 3.2. blaI nucleotide and peptide variation between ST116 and STs 68 and 71.
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FIGURE 3.3. PFGE of nine MRSP isolates. EO-50, EO-55, and EO-64 are European ST71 and closely related by the Tenover et al. criteria. 08-1043,
08-3187, 08-494, and 06-3228 are southeastern US ST68 and closely related by the Tenover et al. criteria. EO-69 and EO-138 are sequence types 73
and 116 respectively.
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mec Sequence Analyses

Promoter sequences for ST68 and ST71 were identical. There was a mecA promoter
single bp polymorphism between ST73 and STs 68 and 71 at mecA -10; this was adjacent
to a mecI/blaI TACA binding motif (solid boxes FIGURE 3.4). Sequence type 116 differs
from STs 68 and 71 by a single base pair difference at the mecA ribosomal binding site
(dashed box FIGURE 3.4).
Repressor mecI sequence was complete and presumed functional in only STs 71 and 73,
SCCmec types II-III and VII respectively.47 In the isolates sequenced for this study, there
was complete homology between ST71 and ST73 in the mecI open reading frame (data
not shown).
Sensor mecR1 sequence was similar between STs 71, 73, and 116, sharing 97%
nucleotide homology. The significance of the slight dissimilarity is unknown. However,
because only mecR1 and not blaR1 can inactivate mecI, mecR1 is presumably a nonessential remnant in ST116. mecR1 in ST71 differs from ST73 by a single bp deletion,
resulting in a frame shift mutation at the C-terminal end of the peptide sequence
(FIGURE 3.5).

bla Sequence Analyses

As was previously reported in “Sequence type selection for further analyses”, ST116 blaI
genomic sequence compared with that of STs 68 and 71 had multiple nucleotide and
translational dissimilarities (FIGURE 3.2). The sensor blaR1 was 100% homologous
between STs 68 and 71. However, peptide composition of BlaR1 between STs 68 and 71
and ST116 was as different as that observed for peptide composition of BlaI (FIGURE
3.6).
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FIGURE 3.4. mecA promoter region polymorphisms of MRSP sequence types. blaI/mecI binding motifs
represented within solid boxes, mecA ribosomal binding site in dashed box.

FIGURE 3.5. mecR1 peptide dissimilarity between STs 71 and 73.
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FIGURE 3.6. blaR1 peptide dissimilarity between ST 116 and STs 71 and 73.
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Relative Quantitation of mecA Expression – ∆∆Ct Method

Each RT-PCR value for the nine isolates below was the result of the analysis of a single
RNA sample. However, growth experiments with RNA extraction and RT-PCR were
performed at least twice with each isolate.
Measurements of mecA mRNA copy number relative to that of the 16S RNA endogenous
control allowed intra-isolate comparisons at differing time points. This method was
useful in illustrating the direction of mecA expression (FIGURE 3.7).
Sequence type 73, which lacked the blaI repressor, showed a stepwise increase in mecA
expression over four hours. Sequence types 68 and 116, each lacking the mecI
repressor, showed induction immediately at one hour, and then maintained elevated
mecA expression at two and four hours. Sequence type 71, which possessed both blaI
and mecI repressors, did not increase mecA expression at any time point at the 0.01
µg/ml oxacillin level.

Quantitation of mecA Expression – Standard Curve

Transcript copy number tied to absolute measurements of known mecA mRNA in a
standard curve make possible inter-isolate comparisons at the different time points
tested. In addition to illustrating the direction of mecA expression, the method allows a
copy production number to be applied to the population of cells producing mecA under
varying oxacillin exposures (FIGURE 3.8).
At four hours growth in 5.0 ml TSB with no oxacillin, mecA copy numbers were 5.39
million to 1.12 million for ST 68s and 71s respectively; though a 4.81 fold difference, this
was not statistically significant (p = 0.6475). However, significance in mecA copy
number disparity between ST68 (+blaI/+blaR1 -mecI/mutmecR1) and ST71 (+blaI/+blaR1
+mecI/+mecR1) isolates were noted at all subsequent induced time points. At one hour
induction, mecA expression was 34.71 million to 0.97 million for ST 68s and 71s
respectively (~35 times greater mecA expression, p = 0.0114). At two hours induction,
mecA expression was 23.76 million to 0.71 million for ST 68s and 71s respectively (~33
times greater mecA expression, p = 0.0158). At four hours induction, mecA expression
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FIGURE 3.7. Influence of repressor gene presence or absence on relative mecA expression, measured at one, two and four hours of growth following
exposure to 0.01 µg/ml oxacillin.
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FIGURE 3.8. Influence of repressor gene presence or absence on absolute mecA expression, measured at one, two and four hours of growth following
exposure to 0.01 µg/ml oxacillin.
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was 38.34 million to 0.65 million for ST 68s and 71s respectively (~59 times greater
mecA expression, p = 0.0046).
Sequence type 116 (mutblaI/+blaR1 -mecI/+mecR1) produced mecA transcript in
amounts equivalent to ST71 (105-106) at all time points. Whereas ST73 (-blaI/-blaR1
+mecI/+mecR1) while increasing mecA output in a time-dependant manner, maintained
the tightest control of mecA expression of the isolates tested.

Effect of Increasing Oxacillin Concentration on mecA Expression

One isolate from each sequence type was exposed to increasing amounts of oxacillin to
determine if and at what level mecA copy number induction occurred (FIGURE 3.9).
Absolute measurement of mecA copy number revealed a one to two log difference
between ST68 (06 3228) and ST71 (e 64) at every oxacillin concentration at which both
isolates grew. No clear mecA induction level was noted for ST71; mecA copy number or
expression did not increase with increased oxacillin concentration. Sequence type 73
showed no mecA induction until a two-log change in copy number at 1.0 µg/ml oxacillin.
Sequence type 116 exhibited a dose-dependent mecA copy increase in response to
increasing oxacillin pressures.

RNAIII Expression in Conjunction with mecA Expression

Measurement of RNAIII at two-hour intervals during log phase growth revealed an
expected sequential increase in RNAIII as population density within the growth chamber
intensified. mecA expression for the ST68 isolate shown (FIGURE 3.10) also increased
with increasing population density for the first five hours, and then reached a plateau
with high-level expression that was maintained through hours seven and nine.

Discussion
The pattern of mecA expression observed in this MRSP study in part parallels previous
reports of how mec and bla regulatory elements contribute to mecA repression in MRSA
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FIGURE 3.8. Absolute mecA transcript production over four hours at increasing concentrations of oxacillin.
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FIGURE 3.10. Gray columns represent RNAIII expression. The black dashed line represents mecA
expression over nine hours. Error bars for columns and dashed line represent standard error of the
mean of technical replicates.
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– BlaI is more permissive at the mecA promoter than MecI.84,85 However, because the
acquisition of mecA by S. pseudintermedius was recent, relative to that which occurred
in S. aureus, the identification of prevailing mec regulatory strategies in regional clones
provides more convincing evidence as to the level of mecA regulation is required for
successful clonal expansion. For MRSP it appears that some level of bla regulatory
control is needed to efficiently express methicillin resistance.
The exclusively MecR1-controlled system (ST73) was slower than the exclusively BlaR1controlled systems (STs 68 and 116) to respond to oxacillin, taking hours to achieve a
comparable response. Sequence type 73 also had the lowest level of constitutive mecA
expression in the absence of oxacillin exposure. It is difficult to extrapolate these and
other in vitro assessments (mecA expression, antimicrobial susceptibility tests, etc.
Kirby-Bauer disc diffusion, MIC) to how infections caused by these isolates will behave in
the patient. However, tight control of mecA by MecI-only systems likely puts these
MRSP and MRSA lineages at a disadvantage in the clinical setting, as induction may not
be rapid enough to prevent cell death when faced with therapeutic levels of beta-lactam
antibiotics.81,95 The paucity of successful mec-only controlled methicillin-resistant
lineages for both S. aureus and S. pseudintermedius suggests that some level of bla
control in mecA expression is necessary for geographic clonal expansion.
Despite having similar bla and mec regulatory apparatuses (blaI repression without
mecI), sequence types 68 and 116 are genetically dissimilar when analyzed by MLST and
PFGE, and contain the distinct SCCmec types V and VI respectively. BLAST analysis of
blaI and blaR1 sequence reveals differing origins for beta-lactamase. Sequence type 116
bla sequence is identical to S. aureus plasmid pWBG748 (GenBank accession no.
GQ915265); whereas ST68 bla sequence matches most closely with beta-lactamasecontaining S. aureus plasmid pWBG756 (GenBank accession no. GQ900472). Both
sequence types respond to oxacillin induction at one-hour post induction and maintain
increased mecA expression at two and four hours. However, mecA transcript copy
number differs between the two sequence types by one to two logs at all time points
and at all oxacillin concentrations measured, suggesting that either the blaI/blaR1 of
ST68 is more permissive than the blaI/blaR1 of ST116, or that additional factors are
affecting mecA expression.
With the singleton comparator strains (STs 73 and 116) removed from the analysis, the
one to two log difference in mecA expression between the North American MRSP ST68s
and European ST71s at all induced time points and at all levels of antibiotic exposure
suggests there exists at least two divergent pathways to geographic clonal success with
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regard to control of PBP2a metabolism. Sequence types 68 and 71 are not genetically
similar when analyzed with MLST and PFGE.77 However, sequence analysis revealed
complete homology in all shared mec and bla regulatory elements – mec promoter, blaI
and blaR1. Sequence type 68 induces at one hour and maintains induction throughout
the assay. Whereas ST71 does not induce in the presence of 0.01 µg/ml oxacillin and
maintains essentially the same level of constitutive mecA expression at all time points
measured. Presumably BlaI and MecI compete for access to the mec operator in ST 71.
This competition could account for the variability observed in the direction of mecA
expression. With increasing oxacillin concentrations ST 71 appears to have a biphasic
response with increased mecA copy number at 0.08 µg/ml and then again at 1.0 µg/ml.
This pattern should be further explored to determine whether BlaR1 and MecR1 differ
in response to oxacillin concentration as well as time.
As of yet there is no known overlap in the geographic areas affected by STs 68 and 71.
These predominant sequence types emerging in North America and Europe with their
distinct mec regulatory strategies are either the product of chance, or are a reflection of
unique environmental pressures. Sequence type 68 has only BlaI/BlaR1 regulation of
mecA, has high constitutive mecA expression, and responds rapidly to small
concentrations of oxacillin. Sequence type 71 has both BlaI/BlaR1 and MecI/MecR1
regulation of mecA, and has less constitutive and induced expression of mecA than
ST68. Because uncontrolled PBP2a production is deleterious86, it has been suggested
that MRSA lineages require some level of bla regulatory control to stabilize the mecA
gene in the absence of beta-lactam antibiotic exposure.85, 91 MecI/MecR1 alone is likely
too restrictive of mecA expression to adequately respond to beta-lactam treatment.
MecI/MecR1 coupled with BlaI/BlaR1 represents a middle ground with ST71 where a
lineage could call on mecA expression if needed; this conformation may indicate that
these isolates evolved in an environment in which antibiotic perturbations were less
frequent. The BlaI/BlaR1 of ST 68 represents the least stringent mecA control, and the
apparent success of this lineage in the United States may indicate a constant need for
some level of PBP2a, possibly due to presence of low-level beta-lactam in the
environment in which they evolved.
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Chapter 4: Conclusions and Application of Findings
The molecular characterization study is now part of a collection of similar
investigations33,45,46,77 that have firmly established ST71 and ST68 MRSP clonal
expansion in Europe and US respectively. The follow-up study is the first to utilize
comparative regulatory gene sequencing and gene expression in MRSP to compare the
two regional clones with regard to differences in gene expression. The approach used in
measuring mecA copy number gave unique insight into not only fold change over
baseline expression, but absolute copy number of mecA mRNA produced in MRSP.
Sequence type 68 exhibited a significantly different mecA response relative to ST71 in
quickness, duration, and number of transcripts when exposed to very small amounts of
oxacillin. This presumably translates to greater PBP2a in ST68 relative to ST71 within
the first few hours of oxacillin exposure. Earlier MRSA studies have not been able to
detect a correlation between beta-lactam mean inhibitory concentration (phenotype)
and cellular concentrations of PBP2a.96,97 We too observed that high and low mecA
production response did not correspond to phenotype. Isolates of ST68 and ST71
exhibited a full range of phenotypic oxacillin resistance, from low-level measurements
near 17 mm by Kirby-Bauer disc diffusion and 0.5 µg/ml by broth microdilution to highlevel resistance ≤ 10 mm and ≥ 4.0 µg/ml respecitively.77,98 This discrepancy between
reproducible amounts of mecA transcript production (measured at one, two and four
hours of oxacillin exposure) and variable disc diffusion phenotype (typically measured at
24 hours of bacterial growth) suggests that expression analysis may be more indicative
of in vivo MRSP response to antibiotic therapy than more traditional measurements.
Clinicians select antibiotics and dosage based upon phenotypic measurements. But
these finding perhaps indicate more aggressive empirical beta-lactam protocols could be
beneficial against clonal lineages like ST71 in Europe that demonstrate more stringent
mecA regulatory control. Further research would be required to bear this out.
In 2003 Rosato et al performed a similar analysis of clinical MRSA isolates, sequencing
regulatory genes and the mecA promoter, and performing mecA expression analysis.
They reported a synergism in isolates with both MecI and BlaI, with lower mecA
transcription than isolates containing either one alone.84 Our observations of MRSP in
Chapter 3 conflict with the Rosato assessment – ST71 with both BlaI and MecI was
intermediate to the high mecA production of ST68 and the low mecA production of
MecI-only ST73. The less-diversified MRSP genetic evolutionary picture may explain this
difference. Heterogeneous resistance is a strategy in many successful MRSA lineages,
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whereby a small subset of bacterial cells in pure culture express high-level methicillin
resistance in response to selection. Multiple genetic factors (in addition to those
examined in these studies) have been shown to affect mecA production in MRSA. We
have been unable to demonstrate heterogeneous methicillin resistance thus far in
MRSP. Perhaps this early less complicated stage of mecA regulatory evolution in MRSP
can be exploited. We’ve demonstrated that some level of beta-lactamase control likely
contributes to the success of STs 68 and 71. Our findings suggest that the membranebound receptor BlaR1 as a prime target for therapeutic control of methicillin-resistant
isolates.
The most lasting aspect of this work will likely be the development of a highly
reproducible MRSP mecA expression assay as an in vitro model to analyze novel
antibiotic approaches. New antibiotics from the traditional development pipelines are
slow in coming and quick to select for resistance. Our model can be used in conjunction
with any approach that could hinder the production of mecA and reinstate the
effectiveness of synthetic beta-lactam antibiotics. The development of a BlaR1- and/or
PBP2a-specific vaccine, the effect of non-cognate auto-inducing peptides, and the
activity of synthetic antisense oligonucleotides on mecA regulatory genes could all
readily be assessed using the mecA expression assay.
MRSP was first identified in 1999.5 UTCVM has been at the forefront of research
institutions in tracking the proliferation of this emerging pathogen from phenotypic,
molecular, and clinical perspectives. At the beginning of this project in 2007 the first
publication hinting at regional clonality had just been published. 33 In the time since, this
dissertation project has contributed to the MRSP knowledge-base with the identification
of ST68 as the regional clone associated with our collection and the United States, and
has brought to light the significant differences in mecA expression strategies between
the European and American regional clones.
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